1. Background {#sec564}
=============

During general anesthesia, endotracheal intubation (ETI) results in stimulation of sympathetic nervous system and catecholamine release and therefore, increase in blood pressure, heart rate (HR) and heart load ([@A6884R1]). Thus, opioids have been used to minimize these responses to short-term stimuli such as ETI in the setting of pediatrics and obstetrics as well as other situations ([@A6884R2], [@A6884R3]). Opioid administration is not recommended in general anesthesia in parturients for cesarean section, because of its depressant effects on newborn. In preeclampsia, however, the sympathetic-suppressing role of opioids seems to be crucial because ETI hypertension already exists and moreover, the ETI-induced catecholamine secretion can result in fetal arrhythmia and intracranial hemorrhage. Apart from that, opioids can decrease fetal perfusion due to their suppressive impact over circulatory system by exacerbation of aortocaval compression ([@A6884R4]). Small doses of fentanyl are acceptable in preeclamptic parturients without adverse effects on newborn ([@A6884R5], [@A6884R6]). Therefore, an agent of short onset and offset of effects such as remifentanil seems to be of great advantage. Remifentanil has unique properties especially in pharmacokinetics which alters negligibly in liver or kidney disorders and age variations. Moreover, its rapid dissipation is a prominent privilege ([@A6884R7], [@A6884R8]).

2. Objectives {#sec565}
=============

The current study aimed to evaluate hemodynamic changes induced by ETI if remifentanil is used compared to fentanyl. The research was carried out for the first time in the setting of cesarean delivery in preeclamptic patients.

3. Patients and Methods {#sec566}
=======================

This randomized trial was carried out in Tehran University of Medical Sciences, department of Anesthesia in Firoozgar hospital, Tehran, Iran. The study was approved by the institutional committee of ethics in Tehran University of Medical Science (No: 4276) and was registered to Iranian Registry of Clinical Trials (Irct ID: IRCT201108294969N2). Written and informed consent was obtained from all patients as well. Patients within the range of 18-45 diagnosed with preeclampsia and candidate for cesarean delivery were considered as subjects of the study. Patients presenting with cardiopulmonary disorders, hyper- or hypothyroidism, history of opioid and/or alcohol misuse, drug history of sedatives, benzodiazepines, alpha and/or beta agonists, beta antagonists and patients with complicated ETI history were excluded from the study. After allocating the patients (by block randomization) into two groups, their heart rate (HR), systolic blood pressure (SBP) and diastolic blood pressure (DBP) were recorded via noninvasive technique (by "ALBORZ B5" monitor made by "Pooyandegan Rah Saadat" Co., Tehran, Iran); also, pulse oximetry was performed in supine position as well. All patients received 500ml intravenous normal saline and were preoxygenated by 6 liters per minute flow of 100% oxygen for five minutes. Thereafter, patients in group one received 50 μg fentanyl (bolus dose), and patients in group two received remifentanil infusion at 0.05 μg/kg/min for three minutes before induction and continued until intubation time. Afterward, rapid sequence induction of anesthesia was commenced with sodium thiopental at 5 mg/kg and then succinylcholine at 1.5 mg/kg (three minutes after fentanyl injection and beginning remifentanil infusion). After cricoid pressure and 60 seconds from the latest injection, ETI was performed and all patients were mechanically ventilated (tidal volume of 10 ml/kg). Maintenance of anesthesia was provided by 0.5% Halothane + 50% N2O in oxygen. The variables of HR, SBP and DBP were recorded before ETI and immediately after that and checking the right place of tube. Apgar index was calculated for each neonate at the 1st minute after delivery. SPSS software Version 11 was employed to perform chi-square and Pair t-tests for statistical analysis.

4. Results {#sec567}
==========

47 patients were enrolled into the study, but 43 were allocated randomly in two group. Two patients in remifentanil group and three in the other were excluded because of difficulties in tracheal intubation and need to more attempts to secure airway and ventilation. Out of remaining 38 patients, 20 and 18 were studied in remifentanil and fentanyl groups respectively. Mean age of patients was 29.14 and 28.91 years, respectively (P \> 0.05). Mean of gestational age of parturients in remifentanil group was 30.11 weeks and in fentanyl group was 29.78 weeks (P = 0.12). Mean of total dose of fentanyl used in the second group was 0.735 μg/kg. [Table 1](#tbl168){ref-type="table"} summarizes the mean values of HR, SBP and DBP in remifentanil and fentanyl groups before and after ETI. These variables had increased in level after ETI in fentanyl group. Of the three variables, HR and DBP demonstrated significant difference (P \< 0.001 and 0.019, respectively). In remifentanil group, however, apart from HR that increased after ETI, SBP and DBP decreased but only differences of the SBP was significant (P = 0.018). This suggests the priority of remifentanil over fentanyl in the patients. [Table 2](#tbl169){ref-type="table"} indicates that there was no significant difference between mean Apgar indexes of neonates in the two groups. The minimum Apgar recorded in both group was 7. The number of neonates with apgar score 7, 8, 9, 10 in remifentanil group were 1, 6, 9, 4 and in Fentanyl group were 1, 7, 7, 3 respectively. No newborn in both groups needed tracheal intubation or ventilatory support.

###### Comparison Between Remifentanil and Fentanyl Groups Regarding Hemodynamic Markers

               Remifentanil Group   Fentanyl Group                    
  ------------ -------------------- ---------------- ---------------- ----------
  **HR**                            0.069                             \< 0.001
  Before ETI   86.85 ± 2.482                         85.17 ± 3.208    
  After ETI    89.20 ± 2.676                         91.94 ± 2.982    
  **SBP**                           0.018                             0.146
  Before ETI   154.35 ± 5.262                        149.50 ± 3.764   
  After ETI    148.35 ± 4.736                        153.11 ± 4.213   
  **DBP**                           0.955                             0.019
  Before ETI   88.55 ± 3.226                         87.61 ± 2.707    
  After ETI    88.40 ± 2.374                         92.22 ± 2.644    

^Abbreviations:^ETI, endotracheal intubation; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure.

###### Comparison Between Remifentanil and Fentanyl Groups Regarding Apgar Index in Neonates 1min After delivery

  \>Apgar Index        No. (Mean ± SD)      *P* value
  -------------------- -------------------- -----------
  Remifentanil group   20 (0.880 ± 0.083)   0.771
  Fentanyl group       18 (0.866 ± 0.084)   0.771

5. Discussion {#sec568}
=============

Remifentanil is known as an ultrashort effect opioid which has a half-life of 1.3 minute. This drug has a higher clearance rate than liver blood flow and significant extra-hepatic metabolism and trivial pulmonary metabolism ([@A6884R9]). Additionally, its concentration ratio between umbilical vein and umbilical artery is 0.88 which does not result in remarkable fetal exposure due to its rapid metabolism ([@A6884R10]). The current study attempted to compare hemodynamic changes in preeclamptic parturients at cesarean delivery after ETI and administration of remifentanil vs. fentanyl. No severe changes were observed in hemodynamic markers of mothers but superiority of remifentanil over fentanyl can be suggested. This is because of significant decrease in SBP in remifentanil group vs. significant increase in HR and DBP in fentanyl group, both after ETI.

Safety and efficacy of remifentanil have been demonstrated in some case series and randomized controlled trials (RCTs) in pregnant women. Roelants et al. used 0.05 µg/kg per minute infusion and 25 μg bolus of remifentanil and observed 5 minutes analgesia during normal vaginal delivery ([@A6884R11]). Moreover, it has been reported by Owen et al. that 34 hours of remifentanil infusion has no noticeable adverse effect on newborn ([@A6884R12]). Furthermore, in the study conducted by Douma et al., superiority of remifentanil over fentanyl and meperidine in labor was provided. This had reduced the need for regional anesthetic support while no change in Apgar index was observed ([@A6884R13]). Palacio et al. also showed no negative impact upon neonates born from parturients with obstetric emergencies when remifentanil bolus dose at 1μg/kg was administered as maintenance in cesarean sections ([@A6884R14]). Although routinely opioids are not drugs of choice in induction of general anesthesia during cesarean section, little amounts of fentanyl is administered in cases with preeclampsia, HELLP syndrome, coagulopathies and patient's refusal of spinal anesthesia ([@A6884R15], [@A6884R16]). In such cases, however, hemodynamic responses to ETI are unavoidable. Because of transient delayed respiratory depression with higher doses of remifentanil was noted in some newborns ([@A6884R17]-[@A6884R20]), in the current study safe dose of this drug that had been previously used in labor, was considered. Opioids was also used in epidural space in pregnant women for cesarean section without significant difference in maternal complications and Apgar scores ([@A6884R21]). Safavi M et al. showed that some drugs such as Nitroglycerin are effective in attenuating the pressor response to tracheal intubation in severe preeclampsia and could be used instead of opioids to control hemodynamic responses ([@A6884R22]). Remifentanil and fentanyl were also used effectively in endotracheal intubation without use of neuromuscular blocking drugs ([@A6884R23], [@A6884R24]). Remifentanil infusion tends to faster wake up test than alfentanil in spinal fusion surgeries ([@A6884R25]) (because of rapid metabolism) and is suggested to be used in situations that require fast effect and rapid recovery of opioid effects. In this regard, it was postulated that remifentanil may perform a prominent role because of its stabilizing impact on heart rate, blood pressure and Apgar index. Low dose remifentanil can be used safely in parturients candidate for cesarean section without noticeable adverse effects on newborn.
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**Implication for health policy/practice/research/medical education:** Opioids are useful in minimizing sympathetic responses after endotracheal intubation. Administration of these drugs is not recommended in pregnant women candidate for cesarean section, due to their depressant effects on newborn, but in special conditions such as preeclampsia, low doses of fentanyl could be used without maternal or newborn side effects. Remifentanil, an opioid with rapid onset and fast metabolism can be a good alternative for other drugs in these situations.
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